Search research articles
Contact Us
Filters
Showing results (91-100 of 166) with videos related to
Page
of 17
Sort By:
BMJ Open
|
August 8, 2023
Results of the Meso-ORIGINS feasibility study regarding collection of matched benign-mesothelioma tissue pairs by longitudinal surveillance
Katie Ferguson, Matthew Neilson, Rachel Mercer, et al.
Chest
|
December 11, 2003
Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists
Y C Gary Lee, Michael H Baumann, Nick A Maskell, et al.
Nuclear Medicine Communications
|
January 5, 2018
18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma
David O Hall, Clare E Hooper, Julie Searle, et al.
BMJ Open
|
November 10, 2022
Protocol for a prospective observational cohort study collecting data on demographics, symptoms and biomarkers in people with mesothelioma (ASSESS-meso)
Ruairi J H Conway, Jenny Symonds, Deborah Walton, et al.
BMJ Open
|
December 26, 2024
Pragmatic non-inferiority Randomised trial Investigating Needle aspiration versus ChEst drain for Secondary Spontaneous Pneumothorax (the PRINCE-SSP study): study protocol for a randomised non-inferiority trial
Steven Walker, Ellie Taylor, Amy McAndrew, et al.
Respiration; International Review of Thoracic Diseases
|
November 14, 2017
A Prospective Study to Evaluate a Diagnostic Algorithm for the Use of Fluid Lymphocyte Subset Analysis in Undiagnosed Unilateral Pleural Effusions
Giles Dixon, Rahul Bhatnagar, Natalie Zahan-Evans, et al.
Pilot and Feasibility Studies
|
September 3, 2022
A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) - a randomised feasibility study using the trial within a cohort (TwiC) methodology
Anna C Bibby, Natalie Zahan-Evans, Emma Keenan, et al.
Annals of the American Thoracic Society
|
April 12, 2016
Unilateral Pleural Effusions with More Than One Apparent Etiology. A Prospective Observational Study
Oliver J Bintcliffe, Clare E Hooper, Iain J Rider, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 19, 2025
Serum mesothelin as a response biomarker in pleural mesothelioma
Geraldine A Lynch, Jenny Symonds, Anna Morley, et al.
Emergency Medicine Journal : EMJ
|
May 22, 2021
Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study
David T Arnold, Marie Attwood, Shaney Barratt, et al.
Page
of 17
Search research articles
Search
Showing results (91-100 of 166) with videos related to
Sort By:
Page
of 17
BMJ Open
|
August 8, 2023
Results of the Meso-ORIGINS feasibility study regarding collection of matched benign-mesothelioma tissue pairs by longitudinal surveillance
Katie Ferguson, Matthew Neilson, Rachel Mercer, et al.
Chest
|
December 11, 2003
Pleurodesis practice for malignant pleural effusions in five English-speaking countries: survey of pulmonologists
Y C Gary Lee, Michael H Baumann, Nick A Maskell, et al.
Nuclear Medicine Communications
|
January 5, 2018
18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma
David O Hall, Clare E Hooper, Julie Searle, et al.
BMJ Open
|
November 10, 2022
Protocol for a prospective observational cohort study collecting data on demographics, symptoms and biomarkers in people with mesothelioma (ASSESS-meso)
Ruairi J H Conway, Jenny Symonds, Deborah Walton, et al.
BMJ Open
|
December 26, 2024
Pragmatic non-inferiority Randomised trial Investigating Needle aspiration versus ChEst drain for Secondary Spontaneous Pneumothorax (the PRINCE-SSP study): study protocol for a randomised non-inferiority trial
Steven Walker, Ellie Taylor, Amy McAndrew, et al.
Respiration; International Review of Thoracic Diseases
|
November 14, 2017
A Prospective Study to Evaluate a Diagnostic Algorithm for the Use of Fluid Lymphocyte Subset Analysis in Undiagnosed Unilateral Pleural Effusions
Giles Dixon, Rahul Bhatnagar, Natalie Zahan-Evans, et al.
Pilot and Feasibility Studies
|
September 3, 2022
A trial of intra-pleural bacterial immunotherapy in malignant pleural mesothelioma (TILT) - a randomised feasibility study using the trial within a cohort (TwiC) methodology
Anna C Bibby, Natalie Zahan-Evans, Emma Keenan, et al.
Annals of the American Thoracic Society
|
April 12, 2016
Unilateral Pleural Effusions with More Than One Apparent Etiology. A Prospective Observational Study
Oliver J Bintcliffe, Clare E Hooper, Iain J Rider, et al.
Lung Cancer (Amsterdam, Netherlands)
|
July 19, 2025
Serum mesothelin as a response biomarker in pleural mesothelioma
Geraldine A Lynch, Jenny Symonds, Anna Morley, et al.
Emergency Medicine Journal : EMJ
|
May 22, 2021
Predicting outcomes of COVID-19 from admission biomarkers: a prospective UK cohort study
David T Arnold, Marie Attwood, Shaney Barratt, et al.
Page
of 17